Nektar Therapeutics earnings per share and revenue

NKTR earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.21 USD which accounts for -4.54% surprise. Company revenue for the same period amounts to 23.89 M USD despite the estimated figure of 21.43 M USD. Estimated earnings per share for the next quarter are -0.19 USD, and revenue is expected to reach 15.34 M USD. Also watch annual changes over time to get a bigger picture of NKTR earnings per share and revenue dynamics.